Ischemic cerebrovascular disease, a major public health problem, is accompanied, and possibly caused in a large percentage of cases, by extracranial arterial lesions. A rapidly expanding body of surgical litera ture records the success of procedures designed to re pair these lesions along with a decline in recent years in surgical mortality for such procedures. If an area of carotid abnormality is a constant threat to adequate cerebral blood flow, why not remove it? There is no fully documented analysis of replies to this important question, but the present view addresses five areas of study that may result in a postponement or rejection of the decision to operate. These areas are not mutually exclusive; rather, they are variables that interact and should be considered in conjunction.
Availability of Nonsurgical Prophylactic Treatment
There is little evidence that surgical or medical treat ment produces major reversals in deficits of cerebral function already caused by cerebral infarction. Treat ment is primarily directed toward prevention of future ischemic episodes. At the present time two medical treatments are available: anticoagulants and platelet aggregation inhibiting agents. No justice can be done here to the massive body of literature on prophylactic results with these agents; however, discussion of the surgical decision would be incomplete without a brief comment on the current status of medical treatment.
Despite decades of study, the place of anticoagu lants in ischemic cerebrovascular disease remains un certain. Although several studies have reported the success of these agents in preventing further ischemic attacks, there are only four well-designed prospective controlled studies. One major problem, as in most studies of treatment of this condition, has been that of properly defining controls. All patients with transient ischemic attacks are not alike. The large number of variables that should be considered in stratifying pa tients has been thoughtfully discussed by Brust, 1 but no study has done this stratification completely. Uncer tainty persists as to the actual prognosis in various types of TIA patients. In one recent follow-up study of 314 patients with TIAs, there was an amazingly low occurrence of 4.8% brain infarction in their patients, only 3.5% of whom had had carotid endarterectomy. 2 The authors postulate that the favorable prognosis may have been due to a more youthful group of patients. In a 1975 review of the older studies on the use of antico agulants in TIAs, Kuller concluded that the random ized studies showed a decrease in the frequency of TIAs and a small decrease in the number of completed strokes and stroke-related deaths. Particular importance has been given to the use of anticoagulants in the period immediately after TIA or RIND. 6 In summary, anticoagulation remains a viable alternative, particularly on a short-term basis, but there is still uncertainty about its role vis-a-vis surgery and the treatments discussed below. One recent random ized study of anticoagulants and platelet aggregation inhibitors in TIA patients found only 3.3% of antico agulated patients to have sustained cerebral infarction during a two-year follow-up. 7 More interest in recent years has centered on the use of the antiplatelet-aggregating agents, such as aspirin, dipyridamole, and sulfinpyrazone, in ischemic cere brovascular disease. Four prospective controlled stud ies summarized by Dyken in 1979 8 reported decrease in transient ischemic attacks, cerebral infarction, and death in the groups treated with aspirin, and two more recent studies support these results.
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The effective ness of other antiplatelet agents in this area has not been extensively studied. Several cases of increasing atherosclerotic arterial disease in patients under aspirin therapy have recently been reported, and it has been suggested that the drug may conceal the symptoms of progressive damage to extracranial arteries. 9 There is no published study comparing surgical and platelet aggregation inhibition treatment of ischemic cerebro vascular disease, nor is there a study of the clinical and angiographic characteristics of patients in whom the antiplatelet agents either failed or succeeded in pre venting further ischemic episodes.
In summary, at present, when carotid endarterec tomy for prophylaxis of ischemic cerebrovascular dis ease is considered, its risk-benefit must be weighed against the two nonsurgical treatments, although their efficacy in relation to each other and to surgical treat ment remains largely unknown.
II. Age
Given the possibility of surgical or nonsurgical treatment, to what degree is age of the patient a contra indication to operation? Increasing numbers of patients in the eighth, ninth, and tenth decades of life are being evaluated for these problems. The incidence of cere bral infarction rises with age, reaching a level of 25 per 1,000 in the 75 to 84 age group. 10 Harbrecht et al. in a recent review commented: "The majority of serious problems in some operations occurred in patients over 75. The projected increase in that age group by the year 2000 is 60% contrasted to a projected increase of only 25% in those aged 65 to 74."" How much is advanced age a contraindication to the carotid operation? We have little data with which to answer this question. Average life expectancy now for the 75-year-old is ten years, for the 80-year-old seven and a half years. Poor results in surgical procedures in general are not reported as directly related to the ages of patients. 12 On the other hand, the aged frequently have multiple diseases, notably cardiac, and cerebral blood flow is reduced. Furthermore, a recent study describes the frequent failure of autopsies to account for death in the very aged and points out the occurrence of "debility and death of older persons from causes that would not have had serious consequences at younger ages. This phenomenon can be understood on the basis of the universal progressive decline in the function of physiological processes with increasing age." 13 There is little specific information on advanced age as a risk factor in carotid artery surgery. In 1979 Ranson et al. found a 10% rate of myocardial infarction and 20% of moderate or severe new strokes in their operated patients aged 70 or older.
14 Sundt et al. identi fy as a "major medical risk" age of over 70."
III. Concomitant Medical Disease
Medical conditions may impinge on the endarterec tomy decision in two ways: (a) the risk in the peri operative and immediate postoperative period may be prohibitively increased, and (b) the prognosis for longterm good health may be poor.
The usual problem is accompanying cardiac dis ease. Concerning the long-term prognosis, numerous follow-up studies of TIA patients have reported a high rate of death from myocardial infarction. 16 As Ennix et al. recently pointed out, "The natural histories of ca rotid and coronary artery occlusive diseases are cer tainly intertwined." 17 Whether symptomatic athero sclerotic heart disease is of such a degree as to make operation on a diseased carotid not worth while is rarely discussed. Likewise, whether the option of mul tiple operations (e.g., carotid-coronary) will alter these decisions in the future is at present not known.
The perioperative surgical mortality in patients known to have coronary disease has been very high; in one recent series of patients with cardiac symptoms, it was 18.2%.' 7 It is also well known that the risk of perioperative stroke is increased in these patients. Two comparatively new developments, however, are re ported to affect operative risk.
First, the preparation for carotid surgery by prelimi nary or concomitant coronary bypass of patients who are known to have cardiac disease has been reported to lower mortality markedly. 17 It is apparent that the tran sient ischemic attack is probably as much a warning in the elderly of generalized, but particularly coronary, arterial disease as it is of carotid-vertebral disease. In the absence of overt cardiac disease, should patients have coronary angiography prior to carotid endarterec tomy? Certainly, with the known high risk of myocar dial infarction in this population, advanced coronary artery disease might well be demonstrated in many such patients and would raise the question of prophy lactic coronary artery surgery.
The second new development promising decreased risk to patients with cardiac disease is the particular and meticulous attention to cardiopulmonary function during the operative period by a team that includes a cardiologist. 18 Despite these advances in care of patients with known cardiac disease, the degree of increased risk will clearly contraindicate operation in some individ uals. In long-term follow-up of patients with TIAs, as noted previously, the most frequent cause of death is myocardial infarction; other cardiovascular disease is, of course, also common.
In determining the patient's over-all prognosis, hy pertension is also an important prognostic feature. It is associated with diminished survival rates undoubtedly because of concomitant cardiac disease. One recent study showed that a history of hypertension was a more reliable prognostic factor than the finding of an elevat ed blood pressure at the time of admission.
IV. Arterial Lesions of Questionable Relevance to the Patient's Clinical State
Problems abound in the decision about carotid end arterectomy when a significant carotid lesion is identi fied on the same side as the patient's transient hemi spheric dysfunction. What should be done when a carotid lesion is discovered in a patient without TIAs or whose TIAs do not clinically "fit" the diseased artery? This question includes several clinical-angiographic problems:
1. The asymptomatic patient with a carotid bruit who is found to have a carotid lesion on angiography. The prognosis of these patients has been studied in several series, 19 and there is a definite discrepancy of opinion. Although several studies have documented an increased incidence of cerebral infarction in these pa tients, the strokes have not been consistently related to the artery producing the bruit. 20 Again, there are no data comparing medical and surgical treatment.
2. The patient with only vertebrobasilar TIAs who on angiography has only a carotid lesion. This problem also has not been extensively studied. If the attacks are definitely vertebrobasilar in nature, it seems probable that the carotid lesion was a coincidental finding and there is no guarantee of benefit from surgery.
3. The patient with carotid TIAs who is found to have a lesion only on the "incorrect'' or opposite side.
4. The patient with consistently unilateral TIAs who has bilateral carotid lesions.
The only evidence on these subjects is a follow-up of patients who have had carotid endarterectomy of a "symptomatic" lesion in the presence of a known "asymptomatic" one. Recurrent episodes on the endarterectomized side are as frequent as those referable to the previously asymptomatic carotid lesion (opposite side). In general, then, the more "inappropriate" the carotid lesion is to the nature of the patient's attacks, the less efficacious is surgery as prophylaxis and the more dubious the benefit-risk ratio. There is almost universal agreement at present that operation on an occluded carotid artery in the presence of an acute stroke is contraindicated. Functional resto ration of flow in any totally occluded artery is appar ently difficult. It would seem that restoring flow to the hemisphere by opening an occluded carotid might pro vide insurance against further ischemia. Whether the procedure does so, however, has not been established. Furthermore, there is evidence that spontaneous recanalization of occluded carotid arteries occurs.
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Accurate decisions in these five types of patients obviously would demand meticulously designed stud ies of huge groups of patients. It is not surprising therefore that at present only fragmentary evidence is available.
V. Severity of Neurological Deficit
Ischemic cerebrovascular disease occurs primarily in the elderly, and in the decision to operate on a diseased carotid artery, concomitant neurological dis ease should be evaluated.
Although patients with minor neurological deficits from previous infarcts or hemorrhages should not be disqualified from surgery, the risk-benefit ratio would probably contraindicate operation in those with, for example, global aphasia and dense hemiplegia. The degree of deficit that would make operation not "worthwhile," such as aphasia alone or severe ataxia, has not been thoroughly discussed. Patients with multi-infarct dementia, impairment of mental status as a sequel to repeated infarcts, would not seem to war rant surgery.
Among other common accompanying diseases, Alz heimer's disease is of note because of its extreme fre quency in the elderly. It is generally relentlessly pro gressive, leading to severe dementia, and when it occurs in association with carotid disease, the condi tion clearly would contraindicate operation. The same caution applies, of course, to other progressive neuro logical diseases, one group of which, brain neoplasia, is occasionally misdiagnosed as ischemic cerebrovas cular disease.
In summary, lesions of the extracranial carotid ar teries usually occur in patients with a variety of prob lems that may influence the decision to operate. There is at present no formula for assessing the importance of any single problem or of several in combination in making this decision.
